Lanxess stock: November 5 results date sets the next test for Lanxess stock

Published on 10/22/2026 at 17:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 6.48 percent to EUR 1.56 billion. Lanxess stock costs EUR 11.99 on October 22, 2026, up 0.25 percent versus Xetra close.

Reporting date ahead

LANXESS scheduled its third-quarter 2026 results for November 5, 2026.
Second-quarter revenue rose 6.48 percent to EUR 1.56 billion.
Lanxess stock costs EUR 11.99 at Lang & Schwarz on October 22, 2026 at 5:36 p.m. CEST, 0.25 percent above the Xetra close of October 22, 2026 and 45.55 percent below the 52-week high.
Lanxess had a EUR 1.0 billion market capitalization and a negative trailing P/E of -1.54 on October 22, 2026.

Aquarellmalerei einer Rheinstadt mit Kathedrale und Industrieanlagen im Hintergrund — Lanxess AG (DE0005470405) mit Sitz nahe Köln, dargestellt als Aquarell-Stadtansicht am Rhein mit Industrie, Illustration mit AI erstellt.

LANXESS (ISIN DE0005470405) has scheduled its third-quarter 2026 results for November 5, 2026, giving investors the next fixed date for assessing the specialty chemicals group's recovery. The company posted second-quarter revenue of EUR 1.56 billion, up 6.48 percent from EUR 1.47 billion in the second quarter of 2025, according to LANXESS. The stock was trading at EUR 11.99 at Lang & Schwarz on October 22, 2026 at 5:36 p.m. CEST, up 0.25 percent versus the Xetra close of October 22, 2026 at EUR 11.96.

Revenue growth remains modest

The second-quarter sales increase was measured against a EUR 1.47 billion comparison base from the prior-year quarter. That puts the upcoming November report in a clear operating context: the next test is whether higher sales can translate into stronger earnings rather than revenue growth alone.

LANXESS operates across advanced intermediates, specialty additives, consumer protection and engineering materials. Its investor page describes the group as a specialty chemicals producer with sales of EUR 6.4 billion in 2024 and about 12,000 employees in 32 countries.

Stock stays near its yearly low

At EUR 11.99, the share price stood EUR 0.96, or 8.70 percent, above the 52-week low of EUR 11.03 and EUR 10.03, or 45.55 percent, below the 52-week high of EUR 22.02 on October 22, 2026. The market capitalization was EUR 1.0 billion and trading volume reached 398,414 shares on the same date.

The price position matters because the stock's trailing P/E was -1.54 on October 22, 2026, indicating that the valuation measure reflects losses rather than positive earnings. BASF was valued at EUR 45.2 billion with a P/E of 7.88, while Symrise carried a EUR 14.1 billion market capitalization and a P/E of 38.59 on October 22, 2026. Lanxess was up 0.25 percent against its Xetra close, compared with a 0.38 percent decline for BASF and a 1.83 percent gain for Symrise.

What does November 5 add?

The November 5, 2026 reporting date is the next concrete checkpoint for revenue, earnings and margin development. LANXESS said its third-quarter statement and investor conference call will take place on that date at 1:00 p.m. CEST. The company also plans to publish its quarterly statement and investor summary then.

Stock price and investor frame

For investors, the next report must show whether the second-quarter revenue increase is accompanied by better profitability. The share remains only 8.70 percent above its 52-week low, while the negative trailing P/E underscores the importance of the earnings figures due on November 5, 2026.

LANXESS was trading at EUR 11.99 at Lang & Schwarz on October 22, 2026 at 5:36 p.m. CEST, up 0.25 percent versus the Xetra close of October 22, 2026 at EUR 11.96. The further course of trading is shown by the continuously updated real-time quote of Lanxess stock.